[et_pb_section fb_built=”1″ admin_label=”News T-Hero Section” module_class=”hero tert” _builder_version=”4.27.3″ _module_preset=”default” background_image=”https:\/\/aafa.org\/wp-content\/uploads\/2022\/07\/AAFA-Website_Tertiary_News.jpg” background_position=”top_right” custom_padding=”1%||1%||true|false” global_module=”2297″ saved_tabs=”all” collapsed=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” background_enable_image=”off” background_size=”initial” background_position=”bottom_left” background_horizontal_offset=”0%” custom_margin=”||||false|false” custom_padding=”2%||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Nav Parent Title” module_class=”tert-parent” _builder_version=”4.20.4″ _module_preset=”default” header_2_font=”|600|||||||” header_2_text_align=”left” header_2_text_color=”#FFFFFF” header_2_font_size=”32px” custom_margin=”||0px||false|false” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][et_pb_code admin_label=”Breadcrumbs” module_class=”bcrumb” _builder_version=”4.17.4″ _module_preset=”default” text_orientation=”left” custom_margin=”||||false|false” custom_padding=”||||false|false” custom_css_main_element=”font-size:16px;||color: #fff;” global_colors_info=”{}”][\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Main Content” _builder_version=”4.17.4″ _module_preset=”default” background_enable_image=”off” background_size=”initial” background_position=”bottom_right” custom_padding=”2%||2%||true|false” collapsed=”off” global_colors_info=”{}”][et_pb_row admin_label=”Title Row” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title author=”off” comments=”off” featured_image=”off” admin_label=”Blog Post Title” _builder_version=”4.18.0″ _module_preset=”default” title_level=”h2″ title_font=”|600|||||||” title_text_color=”#008C99″ title_font_size=”39px” meta_font=”|700|||||||” meta_text_color=”#505050″ meta_font_size=”20px” title_font_size_tablet=”30px” title_font_size_phone=”26px” title_font_size_last_edited=”on|phone” meta_font_size_tablet=”20px” meta_font_size_phone=”16px” meta_font_size_last_edited=”on|phone” global_colors_info=”{}”][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=”Content Row” module_class=”blog-single” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Page Content” module_class=”secondary-intro” _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#505050″ text_line_height=”1.5em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” custom_margin=”||3%||false|false” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
Leading allergy medical societies and patient advocacy groups highlight path forward to advance food allergy prevention, treatment, and management<\/em><\/p>\n Washington D.C., March 19, 2026 \u2014 The Asthma and Allergy Foundation of America (AAFA), as well as leading allergy medical societies the American Academy of Allergy, Asthma, and Immunology (AAAAI) and the American College of Allergy, Asthma, and Immunology (ACAAI) and 8 other food allergy advocacy groups call on the U.S. Department of Health and Human Services to take action to reduce the burden of food allergies on individuals and society. The groups are calling for research-backed efforts focused on understanding, preventing, and treating food allergies.<\/p>\n \u201cOn behalf of the nearly 22 million people in the United States with food allergy, we are coming together to call for action,\u201d said Kenneth Mendez, President and CEO of AAFA. \u201cWhile there is no single cause of food allergy, research tells us there are steps we can take to reduce the risk of food allergies and to improve the lived experience of people with food allergies. It is time to move beyond speculative conversations with no evidentiary support. Let\u2019s instead focus on the science and adopt policies that will yield meaningful results.\u201d<\/p>\n In a letter<\/a> sent to Food and Drug Administration (FDA) Commissioner Martin Makary in response to the FDA\u2019s \u201cExpert Panel of Food Allergies\u201d held on February 25, 2026, the groups said:<\/p>\n We recommend that the U.S. Food and Drug Administration specifically focus on the following areas within food allergy, which should result in major policy wins:<\/p>\n 1. Formally endorse the AAAAI\/ACAAI\/CSACI Prevention guidelines, which de-medicalize and simplify early introduction, helping to facilitate implementation. \u201cAs food allergy continues to affect millions of patients and families, it is essential that regulatory decisions be guided by rigorous scientific evidence,\u201d said AAAAI president Carla Davis, MD. \u201cThe AAAAI believes physicians and patient communities play a critical role as partners with regulatory agencies in advancing policies that support evidence-based care. Through collaboration, we can improve access to prevention strategies and treatments while promoting better health outcomes for both individual patients and the broader population.\u201d<\/p>\n “In addition to being the President of the ACAAI, I am also a patient with food allergies and take care of many patients with food allergies,\u201d said ACAAI president Cherie Zachary, MD. \u201cI encourage the FDA to focus on these recommendations that will help advance our understanding and treatment of food allergy as it continues to evolve in both scientific and real-world terms. \u201c<\/p>\n Recent research<\/a> from the Joint Task Force on Allergy Practice Parameters (JTFPP) examined 190 studies involving 2.8 million people to evaluate factors that are associated with food allergy. The study identified 342 risk factors, but the results tell us that there is not a single cause or risk for food allergy.\u00a0<\/strong><\/p>\n Among the risk factors associated with high certainty of developing food allergy are having eczema, seasonal allergies, or wheezing early in life; delaying peanut introduction into diet; and having a mother or sibling with a food allergy. Vaccines are not associated with food allergy risk.<\/p>\n \u201cOur deep dive into food allergy research provides insight into a path forward for better understanding of the risks for developing food allergy,\u201d said Melanie Carver, Chief Mission Officer at AAFA and a contributor to the Joint Task Force report. \u201cWe should use this research to guide policymaking.\u201d<\/p>\n In addition to AAFA, AAAAI, and ACAAI, the following groups endorsed the letter:<\/p>\n Asthma and Allergy Network (AAN)<\/p>\n American Partnership for Eosinophilic Disorders (APFED)<\/p>\n Campaign Urging Research for Eosinophilic Disease (CURED)<\/p>\n Elijah-Alavi Foundation<\/p>\n Food Allergy and Anaphylaxis Connection Team (FAACT)<\/p>\n International FPIES Association (I-FPIES)<\/p>\n The Mast Cell Disease Society (TMS)<\/p>\n U.S. Hereditary Angioedema Association (HAEA)<\/p>\n <\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=”Content Row” module_class=”blog-single” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Press Contact” _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on|||#008c99|” link_text_color=”#008c99″ header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” header_3_font=”|600|||||||” header_3_text_align=”left” header_3_text_color=”#008c99″ header_3_font_size=”28px” global_colors_info=”{}”]<\/p>\n Press Contact:<\/strong> [\/et_pb_text][et_pb_text admin_label=”About ” _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on|||#008c99|” link_text_color=”#008c99″ link_line_height=”1.7em” ul_line_height=”1.7em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” header_3_font=”|600|||||||” header_3_text_align=”left” header_3_text_color=”#008c99″ header_3_font_size=”28px” background_color=”#F5EDDF” custom_padding=”4%|4%|4%|4%|true|true” hover_enabled=”0″ box_shadow_style=”preset2″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n About AAFA<\/strong><\/p>\n Founded in 1953, AAFA is the oldest and largest non-profit patient organization dedicated to saving lives and improving the quality of life for people affected by asthma and allergic diseases through support, advocacy, education, and research. AAFA offers extensive support for individuals and families affected by asthma and allergic diseases, such as food allergies and atopic dermatitis (eczema). Through its online patient support communities, network of regional chapters, and collaborations with community-based groups, AAFA empowers patients and their families by providing practical, evidence-based information and community programs and services. AAFA is the first asthma and allergy patient advocacy group certified to meet the standards of excellence set by the National Health Council. For more information, visit: aafa.org<\/a> and kidswithfoodallergies.org<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" NewsLeading allergy medical societies and patient advocacy groups highlight path forward to advance food allergy prevention, treatment, and management Washington D.C., March 19, 2026 \u2014 The Asthma and Allergy Foundation […]<\/p>\n","protected":false},"author":17,"featured_media":7567,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[32],"tags":[],"class_list":["post-30253","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases"],"acf":[],"yoast_head":"\n
\n
2. Add support for early allergenic food introduction to the 0-1 year WIC package.
3. Focus research into further investigating established risk factors for food allergy, while continuing to rely on high-quality evidence for evaluating potential environmental contributors.
4. Continue to support and cultivate a pragmatic developmental pathway for novel food allergy and anaphylaxis treatments, including reassessing current outcome measures.
5. Create a policy or regulatory framework for adapting the ED05 as the recognized global standard threshold for precautionary allergen labeling on packaged goods.
6. Support additional funding for research into mechanistic causes, prevention, and treatment of non-IgE-mediated food allergic diseases such as food protein enterocolitis syndrome and eosinophilic esophagitis.<\/p>\n
Andy Spears
Public Affairs Manager
Asthma and Allergy Foundation of America (AAFA)
media@aafa.org<\/span><\/a><\/p>\n